<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Hematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann. Hematol</journal-id>
      <journal-title-group>
        <journal-title>Annals of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0939-5555</issn>
      <issn pub-type="epub">1432-0584</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22395437</article-id>
      <article-id pub-id-type="pmc">3433673</article-id>
      <article-id pub-id-type="publisher-id">1443</article-id>
      <article-id pub-id-type="doi">10.1007/s00277-012-1443-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Concomitant plasmacytoma and B cell lymphoma with discordant light chain expression but clonal identity</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Au</surname>
            <given-names>Wing Y.</given-names>
          </name>
          <address>
            <phone>+852-285-53975</phone>
            <fax>+852-287-26896</fax>
            <email>auwing@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wai-Hung</surname>
            <given-names>Lau</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>Kai Y.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>William W. L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Medicine, Queen Mary Hospital, The University of Hong Kong, UMU, 4/F, Professorial Block Pokfulam Road, Pok Fu Lam, Hong Kong </aff>
        <aff id="Aff2"><label>2</label>Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>3</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>3</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2012</year>
      </pub-date>
      <volume>91</volume>
      <issue>10</issue>
      <fpage>1649</fpage>
      <lpage>1651</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>8</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>2</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2012</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2012</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>A 63-year-old patient presented with abdominal pain. A computerized tomogram scan showed a gallbladder mass (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). A positron emission tomogram revealed additional FDG-avid lesions in the sternum, ribs, bilateral humeri, vertebral column, and pelvic bone (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). Magnetic resonance imaging confirmed vertebral lytic lesions (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>). A serum protein electrophoresis showed a monoclonal band (IgA &#x3BB; 16.2g/l), and he was referred for suspected plasma cell myeloma (PCM). A bone marrow biopsy, however, showed 19&#xA0;% infiltration by monoclonal B cells, expressing CD20, but negative for CD3&#x2212;, CD5, CD10, CD138, IgA, IgG, and IgM (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). These cells showed &#x3BA;&#x2212;light chain restriction (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e</xref>, f). Staining with CD138 highlighted less than 1&#xA0;% plasma cells, while the lymphoma cells do not express CD138. In view of the discrepancy, cholecystectomy was performed showing a plasmacytoma (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1g</xref>). The plasma cells were CD138 positive, CD20 negative, and also positive for cytoplasmic lambda chain and IgA, but negative for IgG, IgM, and &#x3BA;&#x2212;light chain restriction. (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1h</xref>, i). They also expressed CD56 and cyclin D1. The double pathology was treated with R-CEOP &#xD7;6 (rituximab, cyclophosphamide, epirubicin, vincristine, and prednisolone) together with maintenance with thalidomide and bortezomib (weekly&#x2009;&#xD7;&#x2009;16 doses) and radiotherapy to both humerus. A complete remission by radiological and serum immunofixation assessment was shown at 1&#xA0;year. He refused an autologous stem cell transplantation (SCT). The clonal relationship between the two lesions was investigated by polymerase chain reaction using IgH VJ primers followed by cloning and sequencing, using DNA from the homogeneous plasmacytoma and microdissected lymphoma cells from the trephine biopsy [<xref ref-type="bibr" rid="CR1">1</xref>]. This showed a direct relationship between the two B cell clones in terms of band size and sequence homology (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1j and k</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>a</bold> Computerized tomogram scan showing a gallbladder lesion (<italic>arrow</italic>). <bold>b</bold> Positron emission tomogram scan showing FDG avid uptake (<italic>arrows</italic>) in the porta hepatis as well as in the sternum, ribs, and femur. <bold>c</bold> Magnetic resonance imaging showing osteolytic lesions in multiple vertebra levels. <bold>d&#x2013;f</bold> Marrow aspirate and trephine biopsy showing heavy lymphoma infiltration with no evidence of plasma cell dyscrasia. The B cells were highlighted by CD20 staining (<bold>f</bold>). <bold>g&#x2013;i</bold> The gallbladder lesion showed sheets of plasma cells with CD138 expression (<bold>g</bold>) negative for kappa light chain (<bold>h</bold>) but expressing lambda light chain (<bold>i</bold>). <bold>j</bold> Polymerase chain reaction using IgH primers on DNA extracted from marrow and gallbladder lesions showing bands of similar band size (<italic>asterisk</italic> and <italic>arrow</italic>). <italic>MW</italic> molecular weight control, <italic>PC</italic> positive control, <italic>NC</italic> negative control, <italic>BM</italic> bone marrow, <italic>TM</italic> tissue material from gallbladder, <italic>H</italic><sub><italic>2</italic></sub><italic>O</italic> water blank. <bold>k</bold> Cloning, sequencing, and alignment showing homology between clones from the two discordant lesions</p></caption><graphic xlink:href="277_2012_1443_Fig1_HTML" id="MO1"/></fig></p>
    <p>This case is interesting in terms of pathogenesis and treatment. In terms of pathogenesis, cases of concomitant B cell lymphoproliferation and plasma cell dyscrasia are rare and usually of independent clones [<xref ref-type="bibr" rid="CR2">2</xref>]. The immunophenotyping and light chain expression do not suggest a common evolution from a lymphoplasmacytoid lymphoma. Our case is characterized by clonal homology but discordant light chain expression, immunophenotype, and morphology. Plasma cell myeloma with discordant light chain secretion is well documented [<xref ref-type="bibr" rid="CR3">3</xref>]. Posttreatment switch in monoclonal protein may also occur after SCT [<xref ref-type="bibr" rid="CR4">4</xref>]. More dramatically, changes in immunophenotype, morphology, and light chain expression in B cell malignancies after rituximab treatment are also recognized [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. However, in our case, the clones occurred concomitantly and upfront in distinct cell lineages<italic>.</italic> This may theoretically result from plasma cell differentiation of the malignant B lymphocytes or a divergent evolution from a primordial B cell clone. Pools of malignant clonotypic B cells are known to exist in PCM patients [<xref ref-type="bibr" rid="CR7">7</xref>]. In terms of treatment, a combination of lymphoma and PCM treatment seems to be effective in controlling both lesions with minimal overlap of toxicity. It is uncertain whether this patient may have survival benefit from an autologous SCT.</p>
  </body>
  <back>
    <ack>
      <sec id="d29e333">
        <title>Open Access</title>
        <p>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Au</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>TS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transformation of diffuse large B-cell lymphoma into pre-B acute lymphoblastic leukemia: clinicopathologic features and clonal relationship</article-title>
          <source>Hum Pathol</source>
          <year>2004</year>
          <volume>35</volume>
          <issue>7</issue>
          <fpage>900</fpage>
          <lpage>903</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2004.04.002</pub-id>
          <pub-id pub-id-type="pmid">15257558</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pantic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schroettner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pfeifer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rawluk</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Denz</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schmitt-Graff</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma</article-title>
          <source>Leukemia</source>
          <year>2010</year>
          <volume>24</volume>
          <issue>4</issue>
          <fpage>885</fpage>
          <lpage>890</lpage>
          <pub-id pub-id-type="doi">10.1038/leu.2009.294</pub-id>
          <pub-id pub-id-type="pmid">20090779</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ando</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Okabe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Miyazawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohyashiki</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>IgA-lambda/IgG-kappa biclonal myeloma in which two clones proliferated in individual sites</article-title>
          <source>Intern Med</source>
          <year>2000</year>
          <volume>39</volume>
          <issue>2</issue>
          <fpage>170</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.39.170</pub-id>
          <pub-id pub-id-type="pmid">10732840</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zent</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Tricot</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jagannath</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Desikan</surname>
              <given-names>KR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation</article-title>
          <source>Blood</source>
          <year>1998</year>
          <volume>91</volume>
          <issue>9</issue>
          <fpage>3518</fpage>
          <lpage>3523</lpage>
          <pub-id pub-id-type="pmid">9558413</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hwang</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>RY</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression</article-title>
          <source>Ann Hematol</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>9</fpage>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Au</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>So</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm</article-title>
          <source>Leuk Lymphoma</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>932</fpage>
          <lpage>936</lpage>
          <pub-id pub-id-type="doi">10.1080/10428190902878463</pub-id>
          <pub-id pub-id-type="pmid">19504395</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conway</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Keever-Taylor</surname>
              <given-names>CA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2009</year>
          <volume>133</volume>
          <issue>10</issue>
          <fpage>1594</fpage>
          <lpage>1599</lpage>
          <pub-id pub-id-type="pmid">19792049</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
